Fig. 7From: Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progressionPromoter ASB2 region gaining methylation in knockouts exhibits hypermethylation in prostate tumor samples compared to matched normal prostate. Scatterplot depicting increased methylation in matched tumor and normal samples (n = 18 per group), with mean and SEM depicted with error bars. Significance determined by paired Wilcoxon signed-rank test with continuity correctionBack to article page